Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
astellas pharma
biotech
life sciences
national blog main
new york blog main
san diego blog main
2
×
san francisco blog main
10x genomics
atlas venture
audentes therapeutics
avidity biosciences
becton dickinson
bluebird bio
boston
boston blog main
boston top stories
cancer
cancer diagnostics
clinical trials
deals
diagnostic device
duchenne muscular dystrophy
dyne therapeutics
facioscapulohumeral muscular dystrophy
gene therapy
idiopathic pulmonary fibrosis (ipf)
joshua brumm
kaleido biosciences
lung cancer
lymphoma
medical device
merck
muscular dystrophy
myotonic dystrophy type 1
nanostring
national top stories
raleigh-durham blog main
rare disease drugs
romesh subramanian
san francisco
What
reach
2
×
adding
ago
aims
biotechs
company
considering
data
deal
decisions
diagnostic
diagnostics
diseases
drug
dyne
early
expand
expected
experimental
eyes
fold
genetic
having
help
humans
ipo
ipos
long
make
medicines
muscle
nanostring
physicians
rare
technology
tests
therapeutics
treatment
veracyte
worked
Language
unset
2
×
Current search:
reach
×
unset
×
" san diego blog main "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal